Douglas Ross - Aug 15, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Chief Scientific Officer
Signature
/s/ Douglas Ross
Stock symbol
OCX
Transactions as of
Aug 15, 2022
Transactions value $
$0
Form type
4
Date filed
8/17/2022, 08:24 PM
Previous filing
Mar 28, 2022
Next filing
Dec 20, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $0 +150K +738.3% $0.00 170K Aug 15, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.